one
biggest
transform
histori
occur
mankind
shift
huntergather
agricultur
lifestyl
millennium
livestock
companion
speci
rumin
swine
poultri
cat
dog
domest
rais
first
surviv
sens
word
livestock
meaning
profit
commerc
sinc
anim
husbandri
evolv
one
import
activ
civil
develop
import
activ
obviou
sinc
proper
manag
land
use
anim
resourc
alway
requir
avoid
malnutrit
famin
develop
countri
countri
intens
farm
essenti
subsist
explos
growth
rate
world
human
popul
complic
pictur
particularli
develop
countri
sourc
dietari
consumpt
farm
fish
demand
near
futur
inevit
intens
farm
anim
speci
lead
onset
diseas
mainli
caus
propag
infecti
pathogen
affect
anim
welfar
reduc
product
worst
case
serious
undermin
economi
nation
case
livestock
anim
pathogen
also
caus
diseas
human
mean
control
erad
implement
among
plethora
infecti
diseas
anim
viral
etiolog
account
high
burden
case
among
relev
veterinari
perspect
fact
approxim
half
import
anim
diseas
caus
virus
accord
oie
classif
terrestri
aquat
notifi
anim
diseas
see
tabl
list
viral
diseas
compris
viru
differ
viral
famili
four
famili
viru
herpesviru
rhabdoviru
poxviru
paramyxoviru
concentr
high
number
diseas
fig
sever
list
anim
viru
diseas
also
transmit
human
zoonot
diseas
either
direct
contact
infect
anim
infect
anim
tissu
fluid
mean
arthropod
vector
impact
public
health
food
secur
thu
prevent
transmiss
infecti
diseas
interfac
import
protect
world
popul
epizoot
pandem
constitut
basi
one
health
concept
prevent
vaccin
remain
one
costeffect
intervent
strategi
infecti
diseas
list
diseas
licens
avail
vaccin
eventu
obtain
classic
product
methodolog
import
except
diseas
caus
retrovirus
classic
vaccin
technolog
success
aquat
diseas
vaccin
fish
far
develop
case
efficaci
vaccin
viral
diseas
anim
success
illustr
erad
rinderpest
probabl
deadli
diseas
cattl
rumin
caus
morbilliviru
use
attenuatedavirul
strain
caus
viru
recent
evid
advic
support
effort
control
emerg
viral
pathogen
primarili
occur
order
avoid
uncontrol
spread
deadli
virus
within
perspect
technolog
vaccin
design
may
constitut
power
platform
rapidli
gener
new
experiment
vaccin
base
previou
knowledg
immun
respons
gener
host
object
vaccin
achiev
specif
stimul
immun
system
enabl
host
mount
effici
desir
longliv
memori
immun
respons
recogn
pathogen
eventu
elimin
present
organ
upon
infect
achiev
provid
appropri
antigen
stimulu
vaccin
activ
cellular
mechan
involv
recognit
nonself
thu
effici
vaccin
need
recogn
nonself
entiti
ideal
abl
stimul
innat
immun
respons
instruct
subsequ
adapt
memori
respons
first
step
carri
either
infect
special
phagocyt
cell
antigen
present
cell
apc
includ
macrophag
dendrit
cell
abl
present
antigen
determin
b
lymphocyt
fig
though
innat
immun
respons
broadli
reactiv
unspecif
strongli
condit
magnitud
composit
specif
adapt
acquir
immun
respons
cellular
pathogen
recognit
receptor
cprr
either
membran
bound
tolllik
ctype
lectin
scaveng
receptor
cytosol
nodlik
riglik
receptor
phagocyt
eventu
bind
pathogen
associ
molecular
pattern
pamp
carri
infect
microb
particular
encount
pathogen
viru
ligand
singl
doubl
strand
rna
intracellular
prr
activ
phagocyt
cell
normal
quiescent
state
induc
gene
transcript
number
costimulatori
molecul
proinflammatori
cytokin
chemokin
well
irfmedi
transcript
type
iinterferon
ifn
cytokin
immun
cell
type
natur
killer
nk
cell
express
function
tlr
specif
detect
viral
pamp
also
activ
typei
interferon
nk
cell
elimin
cell
express
mhc
molecul
reduc
upon
viral
infect
nk
cell
secret
turn
enhanc
phagocyt
activ
macrophag
antigen
present
matur
dendrit
cell
dc
key
player
bridg
innat
adapt
immun
dc
signal
lymphocyt
determin
whether
cell
eventu
involv
fight
viral
infect
fact
exploit
vaccin
base
attenu
virus
replic
live
viru
vector
initi
innat
immun
respons
greatli
augment
qualiti
magnitud
adapt
respons
contrast
elicit
vaccin
base
inert
antigen
inactiv
viru
subunit
vaccin
recent
central
role
dendrit
cell
apc
regul
immun
respons
made
antigen
target
cell
major
subject
specif
immun
stimul
aim
improv
vaccin
efficaci
well
form
immunotherapi
upon
lymphocyt
activ
interact
dc
specif
immun
respons
grant
clonal
expans
b
tcell
capabl
recogn
specif
antigen
take
place
pool
specif
lymphocyt
contain
memori
effector
cell
expand
primari
respons
vaccin
stimulu
upon
infect
viru
antigen
encount
secondari
respons
greatli
increas
potenti
lead
protect
longliv
immun
specif
effector
memori
cell
fig
therefor
two
main
principl
exploit
vaccin
necessarili
specif
memori
design
vaccin
issu
specif
crucial
success
vaccin
approach
adequ
select
antigen
fraction
whole
antigen
antigen
choic
abl
recal
memori
lymphocyt
pool
produc
primari
respons
vaccin
previou
identif
correl
protect
immun
upon
infect
one
logic
approach
vaccin
design
exampl
includ
relev
epitop
induc
neutral
antibodi
made
upon
infect
andor
key
tcell
epitop
respons
helper
cytotox
function
ideal
knowledg
deriv
pathogenesi
viral
infect
target
speci
vaccin
intend
unfortun
type
studi
often
difficult
perform
laboratori
anim
mainli
due
genet
divers
outbr
speci
lack
reagent
marker
cell
phenotyp
character
limit
number
anim
use
experiment
nonetheless
case
pathogenesi
anim
model
diseas
mainli
rodent
correl
well
enough
target
speci
valuabl
inform
obtain
immun
mechan
protect
knowledg
gather
past
decad
viru
research
becom
evid
gener
sens
viru
less
complex
pathogenesi
success
immunoprophylaxi
could
obtain
gener
immun
respons
surfac
antigen
display
virion
andor
viru
infect
cell
viru
exampl
poxviru
herpesviru
asfiviru
respiratori
virus
lentiviru
develop
complex
pathogenesi
ie
induct
persist
replic
immun
privileg
tissu
use
immun
evas
strategi
induct
harm
host
immun
respons
effect
vaccin
elicit
addit
neutral
antibodi
specif
tcell
respons
first
classif
vaccin
outlin
respect
level
immunogen
elicit
inactivatedkil
noninfecti
versu
live
attenu
vaccin
therefor
two
broad
categori
antivir
vaccin
consid
respect
natur
viru
use
live
death
relev
antigen
whole
fraction
fact
licens
vaccin
viral
diseas
avail
date
medic
veterinari
use
could
fall
either
one
categori
dichotomi
help
categor
vaccin
four
gener
type
tabl
categor
type
vaccin
includ
produc
mean
inactiv
methodolog
type
ii
vaccin
includ
attenu
viru
use
vaccin
includ
gener
revers
genet
type
iii
iv
vaccin
includ
compon
fraction
pathogen
use
vaccin
antigen
thu
type
iii
vaccin
would
includ
subunit
vaccin
includ
carrier
micronanoparticl
viruslik
particl
vlp
vaccin
produc
recombin
technolog
prokaryot
eukaryot
cell
inactiv
recombin
vector
express
heterolog
vaccin
antigen
categori
nucleic
acid
vaccin
well
peptid
base
vaccin
could
also
includ
final
type
iv
vaccin
deliv
live
viral
vector
code
express
particular
select
heterolog
vaccin
antigen
obvious
categori
classif
made
depend
formul
vaccin
exampl
inactiv
vaccin
subdivid
compos
whole
inactiv
infect
cultur
purifi
viru
fraction
type
adjuv
use
augment
immun
respons
attenu
vaccin
could
includ
natur
viru
isol
reduc
virul
attenu
viru
gener
serial
passag
viru
rescu
mean
revers
genet
approach
nucleic
acid
vaccin
base
dna
plasmid
selfrepl
rna
molecul
launch
dna
plasmid
encod
viral
replicon
technolog
sever
methodolog
product
antigen
express
use
modif
formul
appli
therefor
potenti
combin
test
experiment
mani
choic
one
anoth
may
depend
experiment
preclin
data
obtain
model
infect
avail
classif
vaccin
technolog
could
done
basi
main
type
immun
provid
mucos
system
humor
cellular
prefer
deliveri
method
oral
parenter
primeboost
combin
see
tabl
inactiv
kill
antivir
vaccin
use
long
base
disrupt
abil
viru
replic
gener
chemic
physic
method
among
chemic
method
use
formaldehyd
organ
compound
cyclic
ester
binari
ethylenimin
bei
wide
use
crosslink
agent
glutaraldehyd
option
inactiv
use
wide
formaldehyd
two
main
caveat
use
crosslink
agent
vaccin
prepar
cite
first
one
potenti
aggreg
lead
disrupt
modif
antigen
epitop
possibl
account
reduc
immunogen
vaccin
usual
requir
two
three
booster
dose
maintain
adequ
last
level
protect
immun
anoth
problem
risk
incomplet
inactiv
lead
exacerb
diseas
partial
suboptim
induc
immun
cooper
infect
mechan
antibodi
depend
enhanc
ade
case
monocyt
macrophag
fcreceptor
bear
cell
infect
viru
complex
nonneutr
antibodi
process
describ
dengu
viru
infect
final
anoth
issu
inactiv
vaccin
overcom
differenti
infect
vaccin
anim
interfer
surveil
diagnost
formaldehyd
react
primarili
protein
bpl
binari
ethylenimin
bei
modifi
mainli
dna
rna
bpl
expect
maintain
high
immunogen
inactiv
virus
howev
report
bpl
may
also
react
amino
acid
includ
cystein
methionin
histidin
certain
modif
protein
may
also
affect
immunogen
bpl
vaccin
similarli
bei
also
shown
react
protein
compound
use
wide
inactiv
foot
mouth
diseas
viru
fmdv
prepar
vaccin
nonetheless
inactiv
vaccin
remain
lead
methodolog
vaccin
product
human
veterinari
use
part
due
effect
adjuv
mainli
aluminum
salt
vaccin
formul
overcom
main
issu
limit
immun
fact
technolog
may
benefit
inactiv
approach
use
hydrogen
peroxid
proton
compound
diethylpyrocarbon
depc
hydrogen
peroxid
could
inactiv
dna
rna
virus
vaccinia
viru
lcmv
wnv
yfv
littl
damag
antigen
structur
thu
minim
effect
immunogen
interestingli
inactiv
approach
render
vaccin
abl
induc
humor
neutral
antibodi
cellular
immun
respons
includ
wnv
lcmv
specif
cytotox
tcell
use
histidineproton
agent
depc
report
abolish
vesicular
stomat
viru
vsv
infect
pathogen
mice
anim
surviv
lethal
challeng
protect
associ
induct
neutral
antibodi
although
report
aros
sinc
first
descript
spite
advanc
made
differ
technolog
stimul
immun
respons
classic
inactiv
methodolog
still
broadli
use
manufactur
mani
vaccin
veterinari
use
part
sinc
manufactur
need
balanc
care
invest
need
adapt
tradit
manufactur
process
new
technolog
expect
profit
classic
inactiv
techniqu
physic
method
exposur
sever
type
radiat
thermal
electromagnet
ioniz
uv
radiat
one
use
human
vaccin
manufactur
live
attenu
viru
vaccin
among
success
form
vaccin
particularli
regard
immunogen
charact
abil
replic
make
vaccin
stronger
induc
innat
respons
featur
critic
may
influenc
outcom
acquir
immun
respons
discuss
sever
veterinari
companion
anim
vaccin
base
attenu
virus
type
vaccin
use
human
side
well
common
featur
share
attenu
viru
vaccin
lost
virul
factor
immunogen
maintain
tradit
method
develop
attenu
vaccin
serial
passag
propag
viru
heterolog
cell
cultur
brain
tissu
rodent
suckl
mice
rabbit
goat
particular
veterinari
use
propag
differ
tissu
usual
end
chang
tropism
exampl
hepatotrop
virus
passag
brain
tissu
unabl
replic
liver
though
acquir
neurovirul
differ
approach
induc
mutat
mutagen
compound
us
nucleosid
analog
temperatur
sensit
mutant
grown
lower
temperatur
unabl
replic
normal
temperatur
host
main
advantag
attenu
vaccin
inactiv
kill
vaccin
subunit
vaccin
relat
wider
present
epitop
sinc
obvious
protein
express
consequ
viru
replic
infect
host
cell
infect
cell
protein
fragment
present
mhci
also
possibl
administr
similar
natur
rout
infect
ie
nasalmucos
rout
influenza
vaccin
immun
respons
elicit
also
similar
infect
includ
trigger
innat
immun
respons
well
humor
andor
cellular
respons
importantli
cost
gener
manufactur
type
vaccin
usual
afford
veterinari
vaccin
market
side
possibl
disadvantag
attenu
viru
vaccin
genet
instabl
allow
revers
virul
lost
replic
phenotyp
problem
relat
immunosuppress
individu
deleteri
effect
attenu
vaccin
use
gestat
anim
usual
account
vaccin
obtain
method
inactiv
process
fulli
control
understood
ie
serial
propag
tissu
cultur
tabl
summar
advantag
disadvantag
kill
attenu
vaccin
diseas
affect
sever
speci
vaccin
safe
specif
rumin
host
might
safe
swine
gener
term
gener
accept
inactiv
vaccin
offer
less
safeti
problem
attenu
vaccin
advanc
knowledg
pathogen
biolog
immunolog
molecular
biolog
allow
carri
ration
vaccin
design
novel
altern
attenu
type
vaccin
develop
particularli
rna
virus
gener
revers
genet
system
ie
abil
rescu
fulli
infecti
viru
clone
viral
genom
transcript
allow
develop
novel
attenu
vaccin
enhanc
safeti
featur
dna
virus
defin
virul
andor
immunomodulatori
gene
allow
delet
homolog
recombin
techniqu
case
modif
genom
allow
introduct
vaccin
import
characterist
veterinari
vaccin
possibl
differenti
infect
vaccin
anim
particularli
import
surveil
diagnost
implement
exampl
maintain
condit
diseasefre
countri
identifi
protect
antigen
fraction
compon
whole
pathogen
isol
andor
produc
clone
express
heterolog
system
bacteri
yeast
plant
eukaryot
cell
includ
categori
subunit
particul
nucleic
acid
vaccin
approach
specif
immun
respons
gener
maxim
magnitud
immun
respons
tend
lower
attenu
vaccin
thu
immun
adjuv
target
strategi
prime
boost
regimen
might
consid
enhanc
immun
respons
subunit
vaccin
sever
advantag
convent
attenu
vaccin
particular
regard
safeti
product
use
system
produc
subunit
vaccin
base
bacteria
yeast
insect
mammalian
cell
recent
system
base
nonfer
approach
live
organ
develop
particularli
plant
insect
plant
two
main
altern
develop
either
genet
modifi
express
transient
antigen
encod
plant
viru
bacteri
vector
live
insect
lepidoptera
recombin
baculovirus
use
infect
insect
larva
transgen
silkworm
also
gener
review
particular
featur
subunit
vaccin
possibl
gener
viru
like
particl
vlp
coexpress
capsid
protein
constitu
virion
devoid
ribonucleoprotein
like
viral
capsid
vlp
compos
geometr
arrang
array
protein
form
repetit
structur
solubl
antibodi
andor
bcell
receptor
interact
high
avid
structur
thu
good
inductor
tcell
independ
respons
addit
vlp
also
intern
process
apc
induc
th
ctl
respons
therefor
potenti
stimul
broader
immun
respons
monomer
form
protein
subunit
anoth
advantag
vlp
produc
varieti
express
system
baculoviru
poxviru
alphaviru
replicon
plant
salmonella
e
coli
yeast
engin
order
even
express
foreign
epitop
immunestimulatori
molecul
form
chimericvlp
coval
link
immunomodul
either
linear
cyclic
peptid
hapten
glycan
vlp
obtain
envelop
virus
bud
cell
express
vlp
compon
case
influenza
viru
special
techniqu
reconstitut
viral
envelop
unilamelar
liposom
term
virosom
synthet
structur
also
complement
immunestimulatori
conjug
even
heterolog
molecul
dna
sirna
antibodi
fragment
review
perhap
veterinari
vaccin
perspect
gener
vlp
subunit
vaccin
deriv
hamper
higher
cost
product
preclud
gener
use
vaccin
product
technolog
instead
use
whole
protein
antigen
immunogen
epitop
previous
identifi
allow
design
synthet
peptid
direct
specif
immun
respons
known
b
tcell
peptid
combin
includ
peptid
vaccin
design
one
advantag
peptid
subunit
protein
vaccin
simpl
product
storag
distribut
well
flexibl
introduc
modif
mutat
highli
chang
virus
spite
advantag
peptid
vaccin
yet
gener
approach
sinc
need
deeper
knowledg
protect
immun
respons
host
speci
intrins
lower
immunogen
peptid
whole
protein
howev
immunogen
enhanc
multimer
strategi
use
micronano
particul
deliveri
coval
attach
peptid
includ
target
signal
facilit
interact
immun
cell
receptor
genet
vaccin
discov
upon
gene
therapi
experi
wolff
felgner
intend
deliv
dna
muscl
cell
use
cation
lipid
contain
dna
fact
dna
uptak
produc
even
absenc
lipid
express
encod
protein
thu
transcript
unit
encod
ha
antigen
place
control
viral
promot
cmv
dna
vaccin
influenza
first
describ
usual
dna
vaccin
deliv
intramuscular
intraderm
inject
first
case
muscl
cell
directli
transfect
express
protein
dendrit
cell
present
interstiti
space
could
uptak
solubl
antigen
take
cell
kill
vaccin
even
transfect
directli
hand
cytosol
express
protein
enabl
mhci
process
either
muscl
dendrit
cell
mhc
upregul
one
consequ
innat
immun
stimul
unmethyl
cpg
motif
upon
receptor
engag
main
advantag
dna
vaccin
eas
design
produc
allow
differenti
vaccin
infect
anim
diva
antigen
process
natur
mimick
immun
respons
induc
viru
replic
thu
stimul
develop
cellular
humor
immun
respons
final
vaccin
strategi
dna
allow
combin
sever
antigen
target
signal
immunostimulatori
molecul
cytokin
chemokin
improv
immun
respons
elicit
dna
vaccin
far
success
mice
model
diseas
dna
vaccin
licens
date
wnv
hors
vh
salmonid
howev
experiment
dna
vaccin
larg
anim
livestock
viral
diseas
still
need
optim
order
achiev
stronger
immun
respons
amount
plasmid
need
immun
may
repres
seriou
disadvantag
handicap
could
address
use
stronger
promot
replicon
base
plasmid
alphaviru
increas
plasmid
uptak
effici
codeliveri
immunestimulatori
molecul
nonetheless
remain
attract
way
rational
design
vaccin
combin
simplic
product
potenti
use
combin
vaccin
approach
prime
boost
recombin
viral
vector
constitut
import
platform
vaccin
design
experiment
vaccin
approach
virtual
infecti
nonpathogen
viru
use
express
foreign
gene
provid
system
recombin
incorpor
express
develop
achiev
differ
rna
virus
previous
attenu
use
revers
genet
system
dna
viru
mean
homolog
recombin
techniqu
among
dna
virus
use
deliv
vaccin
antigen
poxviru
orthopoxviru
parapoxviru
genu
herpesviru
adenoviru
baculoviru
wide
use
experiment
vaccin
trial
main
advantag
dna
virus
rna
virus
relat
higher
stabil
dna
genom
greater
insert
site
avail
bacdna
clone
avail
make
engin
rescu
recombin
viru
convent
laboratori
task
addit
featur
includ
cytoplasm
replic
except
herpesvirus
induct
long
live
humor
cellular
immun
respons
emphasi
strong
activ
mediat
attenu
poxviru
adenoviru
infect
rna
viru
side
sever
virus
differ
famili
use
foreign
gene
carrier
alphaviru
bunyaviru
coronaviru
flaviviru
paramyxoviru
retrovirus
rhabdoviru
possibl
establish
revers
genet
technolog
allow
rescu
infecti
viru
copi
genom
paramyxovirus
potent
induc
humor
cellular
immun
respons
confer
complet
longlif
protect
use
attenu
vaccin
allow
interchang
nucleoprotein
envelop
glycoprotein
relat
famili
member
give
rise
chimer
virus
use
bival
marker
attenu
vaccin
addit
accommod
addit
genet
inform
express
foreign
antigen
maintain
stabil
propag
cell
cultur
therefor
use
also
immun
pathogen
paramyxoviru
infecti
agent
attenu
rhabdovirus
gener
manipul
viral
glycoprotein
phosphoprotein
andor
genom
order
rearrang
offer
similar
characterist
use
vector
deliveri
foreign
gene
includ
induct
innat
adapt
immun
respons
one
addit
advantag
type
vector
absenc
seroposit
human
anim
popul
replic
defici
alphaviru
also
modifi
express
foreign
antigen
use
vaccin
cancer
gene
therapi
studi
interest
characterist
alphavirus
induct
mucos
protect
immun
respons
bunyaviru
identif
virul
gene
nonessenti
growth
vitro
allow
replac
report
gene
viral
antigen
attenu
virus
capabl
sustain
limit
replic
host
enabl
initi
innat
immun
respons
transgen
exampl
outlin
number
strategi
select
design
attenu
vector
vaccin
well
possibl
design
marker
vaccin
elicit
protect
sever
viru
pathogen
simultan
multival
vaccin
convent
approach
vaccin
design
often
suffici
provid
immun
highli
variabl
pathogen
tcell
immun
crucial
protect
tool
molecular
biolog
integr
system
biolog
genom
proteom
structur
biolog
approach
allow
research
identifi
way
improv
qualiti
vaccin
identifi
repertori
potenti
protect
antigen
exampl
high
throughput
sequenc
identifi
presenc
adventiti
viral
pathogen
commerci
vaccin
defect
genom
cell
cultur
line
use
vaccin
product
structur
model
interact
neutral
antibodi
andor
antibodi
fragment
antigen
uncov
molecular
signatur
defin
protect
epitop
cryptic
hidden
epitop
involv
quaternari
structur
anoth
approach
vaccin
antigen
antivir
compound
design
addit
novel
flow
mass
cytometri
technolog
may
help
gain
deeper
knowledg
specif
cell
type
involv
protect
immun
respons
viral
diseas
final
integr
data
vaccin
trial
includ
vaccin
antigen
adjuv
usag
silico
epitop
predict
algorithm
may
allow
develop
platform
experiment
vaccin
antigen
candid
though
approach
far
gener
hold
promis
futur
rational
vaccin
design
relev
viral
diseas
transit
success
experiment
vaccin
industri
product
manufactur
may
becom
bottl
neck
vaccinolog
sinc
veterinari
vaccin
need
fulfil
sever
import
requisit
among
environment
safeti
issu
manufactur
cost
market
prospect
consid
novel
vaccin
technolog
kill
attenu
vaccin
need
adapt
current
product
process
mani
vaccin
never
develop
enough
reach
market
nonetheless
anim
vaccin
research
attract
research
field
mani
advantag
complex
human
vaccin
field
firstli
due
larger
number
target
anim
speci
segment
rumin
livestock
poultri
porcin
equin
companion
anim
aquacultur
anim
vaccin
secondli
lack
deep
knowledg
immun
mechan
lack
reagent
add
difficulti
immun
respons
character
need
possibl
test
efficaci
vaccin
prototyp
target
speci
studi
immun
respons
evok
one
import
differ
speed
process
vaccin
develop
human
vaccin
anoth
import
advantag
possibl
test
innov
approach
test
human
vaccin
develop
follow
chapter
illustr
number
differ
techniqu
provid
antigen
deliveri
order
develop
vaccin
viral
diseas
though
number
techniqu
exhaust
one
show
consid
current
use
laboratori
research
field
anim
health
reader
find
use
exampl
applic
particular
viral
diseas
sinc
techniqu
virtual
appli
viru
pathogen
among
repres
protocol
broad
categori
vaccin
technolog
discuss
discurs
chapter
also
includ
relat
differ
techniqu
protocol
analys
immun
respons
use
adjuv
essenti
part
vaccin
base
nonliv
organ
experi
use
dna
vaccin
larg
anim
